Work

Rivastigmine, a New‐Generation Cholinesterase Inhibitor for the Treatment of Alzheimer's Disease

Year: 2000

Type: review

Source: Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy

DOI: 10.1592/phco.20.1.1.34664

Author: Michael W. Jann

Institutions: Mercer University, Mercer University Health Sciences Center

Language: English

Topic: Cholinesterase and Neurodegenerative Diseases

Subfield: Pharmacology (medical)

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2045562525

FWCI: 1.464

Cites: 42

Cited by: 242

Related to: 10